These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20590579)
1. Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. Gutierrez-Lopez MD; Llopis N; Feng S; Barrett DA; O'Shea E; Colado MI Br J Pharmacol; 2010 Jun; 160(3):772-83. PubMed ID: 20590579 [TBL] [Abstract][Full Text] [Related]
2. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540 [TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment. Gianessi CA; Groman SM; Thompson SL; Jiang M; van der Stelt M; Taylor JR Addict Biol; 2020 May; 25(3):e12768. PubMed ID: 31056846 [TBL] [Abstract][Full Text] [Related]
4. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675 [TBL] [Abstract][Full Text] [Related]
6. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain. Thomas A; Okine BN; Finn DP; Masocha W Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. Sticht MA; Long JZ; Rock EM; Limebeer CL; Mechoulam R; Cravatt BF; Parker LA Br J Pharmacol; 2012 Apr; 165(8):2425-35. PubMed ID: 21470205 [TBL] [Abstract][Full Text] [Related]
9. The role of CB Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744 [TBL] [Abstract][Full Text] [Related]
10. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model. Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182 [TBL] [Abstract][Full Text] [Related]
11. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051 [TBL] [Abstract][Full Text] [Related]
12. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700 [TBL] [Abstract][Full Text] [Related]
13. N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. Burston JJ; Sim-Selley LJ; Harloe JP; Mahadevan A; Razdan RK; Selley DE; Wiley JL J Pharmacol Exp Ther; 2008 Nov; 327(2):546-53. PubMed ID: 18682568 [TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression. Fitzgibbon M; Kerr DM; Henry RJ; Finn DP; Roche M Brain Behav Immun; 2019 Nov; 82():372-381. PubMed ID: 31505257 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism. Blaker AL; Rodriguez EA; Yamamoto BK Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610 [TBL] [Abstract][Full Text] [Related]
17. The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats. Liu J; Pope C Neurotoxicology; 2015 Jan; 46():12-8. PubMed ID: 25447325 [TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Itzhak Y; Martin JL; Ali SF Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019 [TBL] [Abstract][Full Text] [Related]
20. Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Dubreucq S; Matias I; Cardinal P; Häring M; Lutz B; Marsicano G; Chaouloff F Neuropsychopharmacology; 2012 Jul; 37(8):1885-900. PubMed ID: 22434220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]